NCT05266989

Brief Summary

People with fibromyalgia could experience physical and cognitive impairment as well as higher dual-task cost than healthy people when two tasks are performed simultaneously. Transcranial direct current stimulation is a promising non-pharmacological therapy. However, there is insufficient evidence about the intensities dose-response. Therefore, this protocol aims to 1) to compare the effectiveness and the impact of two tDCS intensities (1mA and 2mA) on cognitive, motor, brain functions, and cardiac autonomic modulation; 2) to study the impact of tDCS on the dual-task performance and creativity after applying tDCS in the dorsolateral prefrontal cortex. As hypotheses, a reduction of cognitive-motor interference in dual-task performance and also a modification in neurophysiological parameters, and an improvement in cardiac autonomic modulation are expected. Finally, no different effects are obtained depending on the intensity applied.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 1, 2022

Completed
6 days until next milestone

Study Start

First participant enrolled

February 7, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

March 4, 2022

Completed
10 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 14, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2022

Completed
Last Updated

November 14, 2022

Status Verified

November 1, 2022

Enrollment Period

1 month

First QC Date

February 1, 2022

Last Update Submit

November 10, 2022

Conditions

Keywords

ElectroencephalographyEEGTranscanial StimulationStrength

Outcome Measures

Primary Outcomes (6)

  • Degree of change in electroencephalography (EEG) between pre and post tDCS session

    The Enobio instrument (Neuroelectrics) and Neuroelectrics instrument driver software (NIC1) will be used to record EEG. Theta, alpha and beta power spectrums will be extracted from a 5 minute recording.

    Once before and after each tDCS session

  • Degree of change in heart rate variability (HRV) between pre and post tDCS session

    The Enobio instrument (Neuroelectrics) and Neuroelectrics instrument driver software (NIC1) will be used to record HRV. Time domain (SDNN, RMSSD, RR-interval and pNN50), frequency domain (LFnu, HFnu, LF/HF and total power) and non-linear measures (SampEn, SD1 and SD2) will be extracted from a 5 minute recording.

    Once before and after each tDCS session

  • Degree of change in balance between pre and post tDCS session

    The tests will be static position with eyes open and static position with eyes closed. The test will be performed on a Kistler force platform.

    Once before and after each tDCS session

  • Degree of change in strength between pre and post tDCS session

    The execution of the test consists of performing a concentric contraction of knee flexion and extension six times consecutively and without pause between repetitions at a speed of 60 /s and in a range of movement from 0 to 90 degrees, being 0 full extension and 90 flexion. The test will be performed on the isokinetic dynamometer Multi-Joint 3, Biodex Medical Sistems.

    Once before and after each tDCS session

  • Degree of change in balance, under dual-task condition, between pre and post tDCS session

    Participants will simultaneously perform the balance test (static position with eyes open and static position with eyes closed) and a cognitive task. The cognitive task will consist of two-by-two substractions from a number greater than 100.

    Once before and after each tDCS session

  • Degree of change in strenght, under dual-task condition, between pre and post tDCS session

    Participants will simultaneously perform the strenght test (conducting a concentric contraction of knee flexion and extension six times consecutively and without pause between repetitions at a speed of 60 /s and in a range of movement from 0 to 90 degrees, being 0 full extension and 90 flexion) and a cognitive task. The cognitive task will consist of two-by-two substractions from a number greater than 100.

    Once before and after each tDCS session

Secondary Outcomes (10)

  • Socio-demographic information

    At week 1

  • Physical activity level

    At week 1

  • Impact of the disease

    At week 1

  • Fear of falling

    At week 1

  • Health-related quality of life

    At week 1

  • +5 more secondary outcomes

Study Arms (2)

Fibromyalgia

All participants will randomly participate through three tDCS conditions (1mA, 2mA and sham)

Other: Transcranial Direct Current Stimulation

Healthy Controls

All participants will randomly participate through three tDCS conditions (1mA, 2mA and sham)

Other: Transcranial Direct Current Stimulation

Interventions

Non-invasive technique that modulates the excitability of the cortex by applying low-intensity current

FibromyalgiaHealthy Controls

Eligibility Criteria

Age30 Years - 75 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Healthy and fibromyalgia women living in Caceres (Spain) and the surrounding area

You may qualify if:

  • Be able to communicate with the research staff
  • Have read, understood, and signed the informed consent form

You may not qualify if:

  • Physiatric or neurological disorders
  • Pharmacological treatment for anxiety or depression
  • Substance abuse or dependence
  • Contraindication for physical effort
  • Difficulty in maintaining balance
  • Leg injury that interferes with flexion and extension of the knee
  • Being pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Facultad de Ciencias del Deporte

Cáceres, 10003, Spain

Location

MeSH Terms

Conditions

Fibromyalgia

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Narcis Gusi

    Universidad de Extremadura

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor

Study Record Dates

First Submitted

February 1, 2022

First Posted

March 4, 2022

Study Start

February 7, 2022

Primary Completion

March 14, 2022

Study Completion

March 14, 2022

Last Updated

November 14, 2022

Record last verified: 2022-11

Locations